Key result
In patients with chronic heart failure and paroxysmal atrial fibrillation, 6 months of loop diuretic therapy significantly reduced the maximum pulmonary vein diameter from 22.21 mm to 19.70 mm and terminated AF attacks.
Why the study?
The remodeling of the left atrium and pulmonary veins and their regression during heart failure treatment in CHF patients with different forms of AF was not well characterized.
Does standard therapy including a loop diuretic reduce pulmonary vein dilatation and terminate atrial fibrillation attacks in patients with chronic heart failure?
Cohort (n=431)
No
Does standard therapy including a loop diuretic reduce pulmonary vein dilatation and terminate atrial fibrillation attacks in patients with chronic heart failure?
Loop diuretic therapy in CHF patients with atrial fibrillation may reduce pulmonary vein dilatation and help terminate paroxysmal AF attacks.
PV dilatation on echo in CHF with AF may identify diuretic-responsive patients; leaves open whether remodeling regression improves AF outcomes.
Objective — The study objective was to perform a transthoracic echocardiographic study of the remodeling of the left atrium and the maximum and minimum diameters of pulmonary veins, as well as remodeling regression in the process of heart failure treatment, in patients with chronic heart failure (CHF) and different forms of atrial fibrillation (AF). Material and Methods — The prospective study included patients having CHF with paroxysmal AF (n=38) and permanent AF (n=36) and without arrhythmia (n=225); the patients had their maximum and minimum diameters of the pulmonary vein measured, additionally to the standard echocardiographic protocol, before and after six months of standard therapy including a loop diuretic. Results — Structural changes in the left atrium and pulmonary veins of patients with CHF having permanent atrial fibrillation were significantly more distinct than those in patients with paroxysmal AF, in patients without arrhythmia, and in the control group. A decrease in the maximum and minimum diameters of the pulmonary vein followed by termination of AF attacks within a year of observation was detected after CHF treatment with a loop diuretic in patients with paroxysmal AF and permanent AF. Conclusion — Prescribing loop diuretics to patients with pulmonary vein dilatation detected during transthoracic echocardiography in subjects with paroxysmal AF and permanent AF results in a decrease in PV diameters and termination of AF attacks in paroxysmal AF.
No takes yet. Share an insight, caveat, or question.
Venera V. Kirillova (2022) conducted a cohort in Chronic heart failure and atrial fibrillation (n=431). Loop diuretic (torasemide) vs. Baseline (before therapy correction) was evaluated on Maximum diameter of the pulmonary vein in patients with paroxysmal AF (mm) (p=<0.001). In patients with chronic heart failure and paroxysmal atrial fibrillation, 6 months of loop diuretic therapy significantly reduced the maximum pulmonary vein diameter from 22.21 mm to 19.70 mm and terminated AF attacks.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: